Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions

Immunology Letters

Volumn 148, Issue 2, 2012, Pages 151-162

  Xia, Ping ^a   Fang, Xu ^a   Zhang, Zheng Hua ^a   Huang, Qiong ^a   Yan, Ke Xiang ^a   Kang, Ke Fei ^a   Han, Ling ^a   Zheng, Zhi Zhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

IL 17; IRAK1; MiR 146a; Psoriasis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 17; MESSENGER RNA; MICRORNA 146A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IRAK1 GENE; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGRESSIVE PHASE; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; SKIN BIOPSY; SKIN DEFECT; STABLE PHASE; UPREGULATION;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-17; MALE; MICRORNAS; PSORIASIS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84869841704     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.09.004     Document Type: Article

References (34)

1. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17T cells. J Invest Dermatol 2008, 128:1207-1211.
2. Cai Y., Shen X., Ding C., Qi C., Li K., Li X., et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 2011, 35:596-610.
3. Yan K.X., Fang X., Han L., Zhang Z.H., Kang K.F., Zheng Z.Z., et al. Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris. Br J Dermatol 2010, 163:48-56.
4. Chua J.H., Armugam A., Jeyaseelan K. MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 2009, 11:189-199.
5. Sonkoly E., Wei T., Janson P.C., Saaf A., Lundeberg L., Tengvall-Linder M., et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE 2007, 2:e610.
6. Yi R., Poy M.N., Stoffel M., Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008, 452:225-229.
7. Lerman G., Avivi C., Mardoukh C., Barzilai A., Tessone A., Gradus B., et al. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS ONE 2011, 6:e20916.
8. Ichihara A., Jinnin M., Yamane K., Fujisawa A., Sakai K., Masuguchi S., et al. MicroRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br J Dermatol 2011, 165:1003-1010.
9. Zibert J.R., Lovendorf M.B., Litman T., Olsen J., Kaczkowski B., Skov L. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010, 58:177-185.
10. Nahid M.A., Pauley K.M., Satoh M., Chan E.K. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 2009, 284:34590-34599.
11. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
12. Dai R., Phillips R.A., Zhang Y., Khan D., Crasta O., Ahmed S.A. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008, 112:4591-4597.
13. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103:12481-12486.
14. Maitra U., Davis S., Reilly C.M., Li L. Differential regulation of Foxp3 and IL-17 expression in CD4T helper cells by IRAK-1. J Immunol 2009, 182:5763-5769.
15. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
16. Giovannetti E., Funel N., Peters G.J., Del Chiaro M., Erozenci L.A., Vasile E., et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010, 70:4528-4538.
17. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009, 60:1035-1041.
18. Wang G., Tam L.S., Li E.K., Kwan B.C., Chow K.M., Luk C.C., et al. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol 2010, 37:2516-2522.
19. Ichii O., Otsuka S., Sasaki N., Namiki Y., Hashimoto Y., Kon Y. Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation. Kidney Int 2012, 81:280-292.
20. Turner M.L., Schnorfeil F.M., Brocker T. MicroRNAs regulate dendritic cell differentiation and function. J Immunol 2011, 187:3911-3917.
21. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
22. Niimoto T., Nakasa T., Ishikawa M., Okuhara A., Izumi B., Deie M., et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 2010, 11:209.
23. Bowcock A.M., Shannon W., Du F., Duncan J., Cao K., Aftergut K., et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001, 10:1793-1805.
24. Boldin M.P., Taganov K.D., Rao D.S., Yang L., Zhao J.L., Kalwani M., et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011, 208:1189-1201.
25. Li J., Wan Y., Guo Q., Zou L., Zhang J., Fang Y., et al. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2010, 12:R81.
26. Zhou X., Krueger J.G., Kao M.C., Lee E., Du F., Menter A., et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 2003, 13:69-78.
27. Chatzikyriakidou A., Voulgari P.V., Georgiou I., Drosos A.A. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol 2010, 71:382-385.
28. Chatzikyriakidou A., Voulgari P.V., Georgiou I., Drosos A.A. A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 2010, 77:411-413.
29. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009, 60:1065-1075.
30. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10:R101.
31. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58:1284-1292.
32. Pauley K.M., Stewart C.M., Gauna A.E., Dupre L.C., Kuklani R., Chan A.L., et al. Altered miR-146a expression in Sjogren's syndrome and its functional role in innate immunity. Eur J Immunol 2011, 41:2029-2039.
33. Zilahi E., Tarr T., Papp G., Griger Z., Sipka S., Zeher M. Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjogren's syndrome. Immunol Lett 2012, 141:165-168.
34. Nakasa T., Shibuya H., Nagata Y., Niimoto T., Ochi M. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 2011, 63:1582-1590.